Ozempic Alternatives for Weight Loss
Ozempic is approved for diabetes, not weight loss — here are the options people actually use for weight management.
Ozempic is frequently searched as a weight-loss drug, but it is FDA-approved to treat type 2 diabetes, not for weight management. The same molecule, semaglutide, is approved for weight loss under the brand name Wegovy. If you have been looking at Ozempic for weight loss, it helps to understand the options that are actually intended for that purpose.
This guide compares Ozempic with Wegovy, provider-prescribed compounded semaglutide, and tirzepatide-based options.
Ozempic vs. Wegovy: the key difference
Ozempic and Wegovy are both semaglutide made by Novo Nordisk, but they are approved for different uses and dosing. Ozempic is approved for type 2 diabetes; Wegovy is approved for chronic weight management. Using a diabetes drug off-label for weight loss is a decision only a licensed provider can make with you.
Alternatives people consider
| Option | What to know | |
|---|---|---|
| Wegovy | FDA-approved for weight loss | Semaglutide; ~$1,300+/mo list price |
| Compounded semaglutide | Provider-prescribed, 503A pharmacy | Not FDA-approved; from $199/mo at ZENKAI |
| Zepbound / tirzepatide | Dual GLP-1/GIP | Often strong results; brand ~$1,000+/mo |
| Compounded tirzepatide | Provider-prescribed, 503A pharmacy | Not FDA-approved; from $299/mo at ZENKAI |
About compounded medications
Compounded semaglutide and tirzepatide are prepared by state-licensed 503A compounding pharmacies for an individual patient after a provider consultation. They are not FDA-approved products, are not reviewed by the FDA for safety or effectiveness, and are only appropriate when a licensed provider determines they are clinically suitable for you.
Which is right for you?
The best option depends on your medical history, goals, insurance situation, and how your body responds. A US-licensed provider reviews your intake and recommends an approach. If a GLP-1 medication is appropriate, ZENKAI can prescribe and ship a provider-prescribed compounded option, cash-pay, with no insurance required.
See if a GLP-1 is right for you
Complete a short online intake. A US-licensed provider reviews your history and goals — no insurance required.
Start your free assessmentFrequently asked questions
Can I use Ozempic for weight loss?
Ozempic is FDA-approved for type 2 diabetes, not weight loss. The same molecule (semaglutide) is approved for weight management under the brand Wegovy. Any off-label use is a decision for you and a licensed provider.
What is the closest alternative to Ozempic for weight loss?
For weight management specifically, Wegovy (semaglutide) is the FDA-approved counterpart. Provider-prescribed compounded semaglutide uses the same active ingredient but is not FDA-approved. Tirzepatide-based options are another path.
How much do these cost without insurance?
ZENKAI’s provider-prescribed compounded semaglutide starts at $199/month and compounded tirzepatide at $299/month, cash-pay. Brand-name products typically list much higher. Confirm current pricing at consultation.
This page is for general education and is not medical advice. It does not establish a provider-patient relationship. Compounded semaglutide and tirzepatide are prepared by state-licensed 503A pharmacies, are not FDA-approved, and are only appropriate when a licensed provider determines they are suitable for you. Prescribing and treatment decisions are made independently by licensed providers. Results vary.